Stem cell transplant recipients are at an elevated risk for osteoporosis and bone fractures after transplant which can be disabling or life-threatening. Learn who’s at risk and screenings and treatments options that can help prevent fractures due to bone loss.

Living with graft-versus-host disease (GVHD) can be challenging not only for the patient, but for the patient’s caregiver as well. It is vital for family caregivers to maintain their own health and quality of life while caring for the patient/loved-one. This presentation presents a road map for how to do just that.

The peripheral nerves in our body control our sensation and movement. Damage to the peripheral nerves is called peripheral neuropathy. This video discusses the different types of peripheral neuropathy, causes, risk factors, symptoms, tests to diagnose it and treatment options.

Distintos tipos de infecciones pueden ocurrir después de un trasplante y pueden complicar la recuperación de los pacientes. Esta presentación describe los riesgos de infecciones después de un trasplante, las terapias para tratarlas, y algunas medidas para prevenirlas.

CAR-T cell therapy is a promising new treatment for multiple myeloma. This presentation describes the versions of this therapy that are currently available, their potential complications and side effects, and the risk/benefit calculations in deciding when this treatment is appropriate.

Sexual problems in men after a stem cell transplant is quite common. This presentation reviews various types of sexual dysfunction in transplant recipients and available remedies. Patients are encouraged to learn about these issues and not hesitate to seek help when needed.

Several new therapies have recently been approved to prevent and treat graft-versus-host disease (GVHD) and more are being studied. The new therapies are more effective than the standard GVHD therapies and should result in a lower incidence of GVHD with fewer toxicities for patients, going forward.

Few transplant centers currently have guidelines and support programs to help patients return to work after a stem cell transplant. New return-to-work guidelines and tools have been developed by transplant and other medical specialists help patients return to work after a stem cell transplant.

Stem cell transplant recipients may develop pulmonary complications after transplant. Some, like bronchiolitis obliterans syndrome (BOS) can severely restrict breathing. This presentation describes the symptoms and treatments for these complications with particular attention to bronchiolitis obliterans syndrome.

This presentation reviews some of the short- and long-term cardiovascular toxicities that can develop after stem cell transplantation. It describes strategies that patients and their physicians can use to reduce the risk of developing cardiovascular problems after transplant.